Search Results 41-50 of 17452 for multiple sclerosis
The purpose of this study is to longitudinally measure cognitive performance in patients with multiple sclerosis and progressive immune-mediated ...
Explore resources related to demyelinating diseases, multiple sclerosis and other neurological disorders researched and treated at Mayo Clinic.
Clinical Trials · Early Intensive Versus Escalation Approaches for Relapsing-Remitting Multiple Sclerosis Long Term Extension · More about research at Mayo Clinic.
— Feb. 26, 2014 — The future holds promise for multiple sclerosis research based on advancements of the past two decades according to a review from Mayo Clinic ...
The purposes of this study are to explore the association between female sex, reproductive history and clinical phenotypic variability in multiple sclerosis ...
Multiple sclerosis, commonly known as MS, is a potentially disabling disease of the central nervous system. In MS, the immune system attacks the protective ...
The study included 52 patients with multiple sclerosis, 24 with other types of spinal cord diseases that are often confused with MS, and five with nerve ...
... multiple sclerosis compared with other myelopathy conditions ... Mayo Clinic has described a new clinical sign that is highly specific for the diagnosis of ...
... multiple sclerosis (MS) disease-modifying therapies (DMTs) target the relapsing phase of MS but have minimal impact once the progressive phase has begun. It ...
... multiple sclerosis. The findings appear in Cell Reports. While probiotics have been used for millennia, there are little data showing how a bacterium can ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Thanks to generous benefactors, your gift today can have 5X the impact to advance AI innovation at Mayo Clinic.